Majid H, Kohli S, Sajad, Islam U, Nidhi. The role of branched chain aminotransferase in the interrelated pathways of type 2 diabetes mellitus and Alzheimer’s disease. J Diabetes Metabolic Disord. 2025;24:1–15. https://doi.org/10.1007/s40200-025-01597-6.
Kwak SH, Park KS. Pathophysiology of type 2 diabetes in Koreans. Endocrinol Metab. 2018;33:9–16. https://doi.org/10.3803/EnM.2018.33.1.9.
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Kaabi JA. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends. J Epidemiol Glob Health. 2019;10:107–11.
Diabetes—India. https://www.who.int/india/health-topics/diabetes
Karpha K, Biswas J, Nath S, Dhali A, Sarkhel S, Dhali GK. Factors affecting depression and anxiety in diabetic patients: a cross sectional study from a tertiary care hospital in Eastern India. Ann Med Surg. 2022;84:104945.
Walders-Abramson N. Depression and quality of life in youth-onset type 2 diabetes mellitus. Curr Diab Rep. 2014;14:1–6. https://doi.org/10.1007/s11892-013-0449-x.
Bayani MA, Shakiba N, Bijani A, Moudi S. Depression and quality of life in patients with type 2 diabetes mellitus. Caspian J Intern Med. 2022;13:335–42.
PubMed PubMed Central Google Scholar
Hussain S, Habib A, Singh A, Akhtar M, Najmi AK. Prevalence of depression among type 2 diabetes mellitus patients in India: a meta-analysis. Psychiatry Res. 2018;270:264–73.
Vijay VR, I PK, Kumar M B, Sagetha J. Assessment of quality of life among type 2 diabetes mellitus patients in an urban health center of Tiruvallur District, Tamil Nadu. Cureus. 2024;16: e63320.
Tachibana K, Hirayama R, Sato N, Hattori K, Kato T, Takeda H, et al. Association of plasma claudin-5 with age and Alzheimer disease. Int J Mol Sci. 2024. https://doi.org/10.3390/ijms25031419.
Article PubMed PubMed Central Google Scholar
Arima M, Nakao S, Yamaguchi M, Feng H, Fujii Y, Shibata K, et al. Claudin-5 redistribution induced by inflammation leads to anti-VEGF–resistant diabetic macular edema. Diabetes. 2020;69:981–99. https://doi.org/10.2337/db19-1121.
Article CAS PubMed Google Scholar
Berndt P, Winkler L, Cording J, Breitkreuz-Korff O, Rex A, Dithmer S, et al. Tight junction proteins at the blood–brain barrier: far more than claudin-5. Cell Mol Life Sci. 2019;76:1987–2002. https://doi.org/10.1007/s00018-019-03030-7.
Article CAS PubMed PubMed Central Google Scholar
Kılıç F, Işık Ü, Demirdaş A, Doğuç DK, Bozkurt M. Serum zonulin and claudin-5 levels in patients with bipolar disorder. J Affect Disord. 2020;266:37–42.
Işık Ü, Aydoğan Avşar P, Aktepe E, Doğuç DK, Kılıç F, Büyükbayram Hİ. Serum zonulin and claudin-5 levels in children with obsessive–compulsive disorder. Nord J Psychiatry. 2020;74:346–51.
Hochman E, Taler M, Flug R, Gur S, Dar S, Bormant G, et al. Serum claudin-5 levels among patients with unipolar and bipolar depression in relation to the pro-inflammatory cytokine tumor necrosis factor-alpha levels. Brain Behav Immun. 2023;109:162–7.
Article CAS PubMed Google Scholar
Kung WJ, Lin CC, Liu SH, Chaung HC. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. Diabetes Technol Ther. 2010;12:809–13. https://doi.org/10.1089/dia.2010.0085.
Article CAS PubMed Google Scholar
Moosaie F, Mohammadi S, Saghazadeh A, Firouzabadi FD, Rezaei N. Brain-derived neurotrophic factor in diabetes mellitus: a systematic review and meta-analysis. PLoS ONE. 2023;18:e0268816.
Article CAS PubMed PubMed Central Google Scholar
Wan B-N, Zhou S-G, Wang M, Zhang X, Ji G. Progress on haptoglobin and metabolic diseases. World J Diabetes. 2021;12:206.
Article PubMed PubMed Central Google Scholar
Tanna VL, Go RCP, Winokur G, Elston RC. Possible linkage between α-Haptoglobin (Hp) and depression spectrum disease. Neuropsychobiology. 1979;5:102–13. https://doi.org/10.1159/000117670.
Article CAS PubMed Google Scholar
Maes M, Scharpé S, Meltzer HY, Cosyns P. Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry. 1993;34:690–701.
Article CAS PubMed Google Scholar
Roy M, Majid H, Khan P, Sharma N, Kohli S, Islam SU, et al. CTX-1 and TRACP-5b as biomarkers for osteoporosis risk in type 2 diabetes mellitus: a cross-sectional study. J Diabetes Metab Disord. 2024;23:2055–64.
Article CAS PubMed PubMed Central Google Scholar
Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.
Article CAS PubMed PubMed Central Google Scholar
Abbasi-Ghahramanloo A, Soltani-Kermanshahi M, Mansori K, Khazaei-Pool M, Sohrabi M, Baradaran HR, et al. Comparison of SF-36 and WHOQoL-BREF in measuring quality of life in patients with type 2 diabetes. Int J Gen Med. 2020;13:497–506.
Article PubMed PubMed Central Google Scholar
Majid H, Ul Islam S, Kohli S et al. Diagnostic potential of serum biomarkers including HMGB1 and Klotho in cognitive impairment among type 2 diabetes mellitus patients: a case–control study. Beni-Suef Univ J Basic Appl Sci. 2025;14:124. https://doi.org/10.1186/s43088-025-00703-0
Khaledi M, Haghighatdoost F, Feizi A, Aminorroaya A. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol. 2019;56:631–50.
Maimaitituerxun R, Chen W, Xiang J, Kaminga AC, Wu XY, Chen L, et al. Prevalence of comorbid depression and associated factors among hospitalized patients with type 2 diabetes mellitus in Hunan, China. BMC Psychiatry. 2023;23:1–11. https://doi.org/10.1186/s12888-023-04657-4.
Thour A, Das S, Sehrawat T, Gupta Y. Depression among patients with diabetes mellitus in North India evaluated using patient health questionnaire-9. Indian J Endocrinol Metab. 2015;19:252–5. https://doi.org/10.4103/2230-8210.149318.
Article PubMed PubMed Central Google Scholar
Egede LE, Hernández-Tejada MA. Effect of comorbid depression on quality of life in adults with type 2 diabetes. Expert Rev Pharmacoecon Outcomes Res. 2013;13:83–91. https://doi.org/10.1586/erp.12.86.
Gal Z, Torok D, Gonda X, Eszlari N, Anderson IM, Deakin B, et al. Inflammation and blood-brain barrier in depression: interaction of CLDN5 and IL6 gene variants in stress-induced depression. Int J Neuropsychopharmacol. 2023;26:189–97. https://doi.org/10.1093/ijnp/pyac079.
Article CAS PubMed Google Scholar
Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, et al. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res. 2009;43:962–9.
Parveen R, Kapur P, Kohli S, Agarwal NB. Attenuated brain derived neurotrophic factor and depression in type 2 diabetes mellitus patients: a case-control study. Clin Epidemiol Glob Health. 2022. https://doi.org/10.1016/j.cegh.2022.101016.
Comments (0)